Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.24.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Private Placement [Member]
Preferred Stock [Member]
Preferred Class A [Member]
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Retained Earnings [Member]
Private Placement [Member]
Noncontrolling Interest [Member]
Private Placement [Member]
Preferred Stock [Member]
Preferred Class A [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2021             250,000 1,405,959        
Balance at Dec. 31, 2021             $ 0 $ 0 $ 80,450 $ (76,999) $ 0 $ 3,451
Share based compensation (in shares)             0 75,505        
Share based compensation             $ 0 $ 0 649 0 0 649
Common shares issuable - Founders Agreement             $ 0 $ 0 526 0 0 526
Issuance of common shares and pre-funded warrants at private placement, net of issuance costs (in shares)             0 3,636,365        
Issuance of common shares and pre-funded warrants at private placement, net of issuance costs             $ 0 $ 0 3,205 0 0 3,205
Repurchase of common stock held by InvaGen (in shares)             0 (388,888)        
Repurchase of common stock held by InvaGen             $ 0 $ 0 (1,104) 0 0 (1,104)
Fortress contribution of Baergic Inc             0 0 (99) 0 0 (99)
Issuance of subsidiaries’ common shares for license expenses             $ 0 $ 0 4 0 0 4
Exercise of warrants (in shares)             0 44,900        
Exercise of warrants             $ 0 $ 0 237 0 0 237
Non-controlling interest in subsidiaries             0 0 588 0 (588) 0
Net loss attributable to non-controlling interest             0 0 0 0 (51) (51)
Net loss attributable to common stockholders             $ 0 $ 0 0 (3,552) 0 (3,552)
Balance (in shares) at Dec. 31, 2022             250,000 4,773,841        
Balance at Dec. 31, 2022             $ 0 $ 0 84,456 (80,551) (639) 3,266
Share based compensation (in shares)             0 0        
Share based compensation             $ 0 $ 0 906 0 0 906
Common shares issuable - Founders Agreement             0 0 371 0 0 371
Issuance of common shares and pre-funded warrants at private placement, net of issuance costs             0 1 865 0 0 866
Issuance of subsidiaries’ common shares for license expenses             $ 0 $ 0 6 0 0 6
Exercise of warrants (in shares)             0 14,272,382        
Exercise of warrants             $ 0 $ 1 0 0 0 1
Net loss attributable to non-controlling interest             0 0 0 0 (111) (111)
Net loss attributable to common stockholders             $ 0 $ 0 0 (10,377) 0 (10,377)
Balance (in shares) at Dec. 31, 2023             250,000 25,597,622        
Balance at Dec. 31, 2023             $ 0 $ 3 92,507 (90,928) (928) 654
Issuance of common stock to Fortress (in shares)             0 374,644        
Issuance of common stock to Fortress             $ 0 $ 0 72 0 0 72
Issuance of common stock and pre-funded warrants, net of offering costs - November 2023 public offering (in shares)             0 3,853,400        
Issuance of common stock and pre-funded warrants, net of offering costs - November 2023 public offering             $ 0 $ 1 3,873 0 0 3,874
Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement (in shares)             0 448,000        
Issuance of common stock for license expense (in shares)             0 1,108,270        
Issuance of common stock for license expense             $ 0 $ 0 1,230 0 0 1,230
Shares issued in a private placement offering (in shares) 0 767,085                    
Shares issued in a private placement offering $ 0 $ 0 $ 550 $ 0 $ 0 $ 550            
Noncontrolling Interest, Decrease from Deconsolidation             $ 0 $ 0 $ 178 $ 0 $ (178) $ 0